Altre lingue Patrys Limited

Azioni

PAB

AU000000PAB9

Tempo differito Australian S.E. Altri mercati azionari 03:40:11 24/04/2024			Variaz. 5gg	Var. 1 gen.
0,009 ^AUD	0,00%		0,00%	+12,50%

23/02	Patrys Limited riporta i risultati degli utili per il semestre conclusosi il 31 dicembre 2023	CI
2023	Patrys inizierà la produzione di PAT-DX1 nel primo trimestre del 2024	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment	10/04
Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023	23/02
Patrys to Begin Production of PAT-DX1 in Q1 2024	13/12
Patrys Limited Announces Retirement of Suzy Jones as Director	14/09/23
Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2023	28/08/23
Patrys Reports 'Favorable' Results from Pre-Clinical Study of Cancer Therapy	24/05/23
US Patent Office Grants Patrys Two New Deoxymab Patents	18/04/23
Patrys secures US patents for antibody technology	17/04/23
Patrys Moves Phase One Trial for Brain Cancer Drug to 2024; Shares Tumble 24%	31/03/23
Patrys Limited Announces New PAT-DX3 Data Demonstrates Synthetic Lethality	13/03/23
Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24/02/23
Patrys Unit Secures AU$3 Million R&D Tax Refund	30/01/23
Patrys : Insights Care Magazine \| Interview with Dr James Campbell	30/11/22
Patrys Appoints Global Biotechnology Leader as Chairman - In Preparation for First Clinical Trial for Groundbreaking Cancer Therapy	18/11/22
Patrys Names Chairman	16/11/22
Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022	15/11/22
Patrys : INTERVIEW \| Dr James Campbell on Proactive	17/10/22
Patrys Limited Announces New Preclinical Data for its Full-Sized IgG Antibody, Pat-DX3	16/10/22
Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director	31/08/22
Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2022	30/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Patrys Limited

Azioni

PAB

AU000000PAB9

Altre lingue

Filtri